Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein-Drug Binding: Determination Methods01:22

Protein-Drug Binding: Determination Methods

798
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
798
Drug-Receptor Bonds01:25

Drug-Receptor Bonds

5.4K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
5.4K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

2.2K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
2.2K
Drug Discovery: Overview01:26

Drug Discovery: Overview

13.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
13.5K
Protein Networks02:26

Protein Networks

4.7K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.7K
Protein-protein Interfaces02:04

Protein-protein Interfaces

15.0K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
15.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Revolutionizing drug discovery from natural products: The roles of artificial intelligence and multi-omics in accelerating innovation.

Acta pharmaceutica Sinica. B·2026
Same author

Steam explosion alters the structure of coffee peel dietary fiber and enhances its functional properties and in vitro fermentability.

Food research international (Ottawa, Ont.)·2026
Same author

Association of hypertension and blood pressure control with aneurysm wall enhancement in unruptured intracranial aneurysms: a multicenter propensity score-matched study.

European radiology·2026
Same author

Pressure-Induced Superconductivity at 15 K in van-der-Waals Ferroelectric CuInP<sub>2</sub>S<sub>6</sub>.

Journal of the American Chemical Society·2026
Same author

Public antibody clonotypes and deep learning identify SARS-CoV-2 and HIV broadly neutralizing antibodies in immune repertoires.

Cell reports·2026
Same author

Retraction notice to "Integrated transcriptomic and metabolomic analysis reveals the role of CsCLCN7 in regulating calcium‑magnesium ratio homeostasis in the clam Cyclina sinensis" [Int. J. Biol. Macromol. 334 (2025) 148902].

International journal of biological macromolecules·2026

Related Experiment Video

Updated: Apr 17, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.7K

Explainability Methods from Machine Learning Detect Important Drugs' Atoms in Drug-Target Interactions.

Mrinal Mahindran1, Qingyuan Liu1,2,3, Vishak Madhwaraj Kadambalithaya1,2

  • 1Center for Bioinformatics, Saarland University, Saarbrücken 66123, Germany.

Journal of Chemical Information and Modeling
|April 15, 2026
PubMed
Summary

Explainable AI methods can identify key drug-binding atoms in graph neural networks (GNNs) for predicting drug-target interactions (DTI). These methods highlight chemically relevant features, improving GNN interpretability in drug discovery.

More Related Videos

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.7K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

4.0K

Related Experiment Videos

Last Updated: Apr 17, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.7K
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.7K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

4.0K

Area of Science:

  • Computational chemistry
  • Artificial intelligence in drug discovery
  • Bioinformatics

Background:

  • Predicting drug-target interactions (DTI) is crucial for drug discovery.
  • Graph neural networks (GNNs) show promise for DTI prediction but lack interpretability.
  • Explainable AI (XAI) methods are needed to understand GNN decision-making.

Purpose of the Study:

  • To benchmark explainable AI (XAI) attribution methods for GNNs in DTI prediction.
  • To assess the consistency and biological relevance of XAI attributions.
  • To enhance the interpretability of GNN models for drug discovery.

Main Methods:

  • Benchmarking four XAI attribution methods on GNNs for kinase and G-protein-coupled receptors (GPCR) targets.
  • Assessing method consistency using atom-level intersection over union (IoU).
  • Validating biological relevance by mapping attributed atoms to 3D protein-ligand structures.

Main Results:

  • Modest consistency was observed across different XAI methods.
  • Consensus attributions were highly enriched for atoms contacting the protein binding pocket (up to 76% within 2 Å).
  • Attributed atoms frequently contacted experimentally important residues, like those in the DFG motif.

Conclusions:

  • XAI methods, despite disagreements, can identify chemically meaningful ligand features for DTI prediction.
  • These findings provide a foundation for developing more interpretable GNNs in drug discovery.
  • XAI enhances the understanding of GNNs, facilitating rational drug design.